Early Detection of Malignant Pleural Mesothelioma in Asbestos-Exposed Individuals with a Noninvasive Proteomics-Based Surveillance Tool

• Rachel M. Ostroff ,

  Contributed equally to this work with: Rachel M. Ostroff, Michael R. Mehan

  * E-mail: rostroff@somalogic.com

  Affiliation Clinical Research, SomaLogic Inc., Boulder, Colorado, United States of America

  ⨯
• Michael R. Mehan ,

  Contributed equally to this work with: Rachel M. Ostroff, Michael R. Mehan

  Affiliation Clinical Research, SomaLogic Inc., Boulder, Colorado, United States of America

  ⨯
• Alex Stewart,

  Affiliation Clinical Research, SomaLogic Inc., Boulder, Colorado, United States of America

  ⨯
• Deborah Ayers,

  Affiliation Clinical Research, SomaLogic Inc., Boulder, Colorado, United States of America

  ⨯
• Edward N. Brody,

  Affiliation Clinical Research, SomaLogic Inc., Boulder, Colorado, United States of America

  ⨯
• Stephen A. Williams,

  Affiliation Clinical Research, SomaLogic Inc., Boulder, Colorado, United States of America

  ⨯
• Stephen Levin,

  Affiliation Center for Occupational and Environmental Medicine, Mt. Sinai Medical Center, New York, New York, United States of America

  ⨯
• Brad Black,

  Affiliation Center for Asbestos Related Diseases, Libby, Montana, United States of America

  ⨯
• Michael Harbut,

  Affiliation Environmental Cancer Program, Karmanos Cancer Center, Detroit, Michigan, United States of America

  ⨯
• Michele Carbone,

  Affiliation Department of Pathology, Cancer Research Center of Hawaii, Honolulu, Hawaii, United States of America

  ⨯
• Chandra Goparaju,

  Affiliation Department of Cardiothoracic Surgery, New York University Langone Medical Center and Cancer Center, New York, New York, United States of America

  ⨯
• Harvey I. Pass

  Affiliation Department of Cardiothoracic Surgery, New York University Langone Medical Center and Cancer Center, New York, New York, United States of America

  ⨯